VC  Emergent Technologies

     Office Locations:

7500 Rialto Blvd
Bldg. 2, Ste. 260
Austin, TX 78735
Phone: 512-263-3232
Fax: 512-263-3236



  • Early
  • Seed



  • Consumer Products & Services
  • Life Sciences & Healthcare



    ETI is a venture capital firm that specializes in forming, funding, commercializing, and managing companies for the purpose of converting institutional and university-based technology into high return ventures. Emergent becomes a full time business partner and acts as an active management team with a portfolio company. Once the technology is proven and markets are demonstrated, ultimate value may be achieved through a sublicense, IPO or sale of the technology. As of 2018, Emergent and its industry partners have invested in excess of $500 million in technologies within its 19 portfolio companies.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Cameron Mackie VP of Marketing
    Ed Merrifield Executive Vice President & COO
    Edward K. Clark CFO and General Counsel
    Kris Looney President
    Thomas A. Harlan Chairman & CEO


    Portfolio companies include:

      AeonClad Biomedical
        web link

      Appian Labs
        web link

      Auxano Biomedical
        web link

      Beacon Sciences
        web link

      Caisson Biotech
        web link

        web link

        web link

        web link

        web link

      Pure Protein
        web link

      Pure Transplant Solutions
        web link

      Receptor Logic
        web link

      Reveal Sciences
        web link

      Selenium Bio
        web link


    Recent News: